Skip to main content
NCBI home page
Journal of Clinical Laboratory Analysis logoLink to Journal of Clinical Laboratory Analysis
. 2001 May 3;15(3):105–107. doi: 10.1002/jcla.1010

Commentary: Advances in the laboratory diagnosis of celiac disease

Richard A McPherson 1,✉
PMCID: PMC6808161  PMID: 11344522

Abstract

Anti‐endomysial autoantibodies are very useful in the diagnosis and monitoring of celiac disease (gluten‐sensitive enteropathy) due to their high sensitivity and specificity for that disorder. The recent discovery that the autoantigen responsible for the endomysial pattern is tissue transglutaminase (tTG) has led to the commercial development of automated enzyme immunoassays for quantitation of that autoantibody. These assays are standardized to provide highly accurate and comparable testing between laboratories for anti‐tTG autoantibodies. Celiac disease is a common genetic disease in populations of Europe and the United States. It has a spectrum of expression ranging from silent or mild to severe, with resulting malabsorption that produces multiple‐organ system effects due to malnutrition. Many cases miss the diagnosis because the symptoms are not classic or the clinical syndrome is not severe. Because the treatment of celiac disease (avoidance of wheat products) is so effective and inexpensive and because celiac disease is so common in selective populations, a highly reliable test for its detection such as anti‐tTG should find wide application in clinical practice. J. Clin. Lab. Anal. 15:105–107, 2001. © 2001 Wiley‐Liss, Inc.

Keywords: celiac disease, gluten‐sensitive enteropathy, gliadin, tissue transglutaminase, endomysial antibody, autoantibody

REFERENCES

  • 1. Jaskowski TD, Schroder C, Martins TB, Litwin CM, Hill HR. 2001. IgA antibodies against endomysium and transglutaminase: a comparison of methods. J Clin Lab Anal 15:108–111. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2. Basso D, Gallo N, Guariso G, Pittoni M, Piva MG, Plebani M. 2001. Role of anti‐transglutaminase (anti‐tTG), anti‐gliadin and anti‐endomysium serum antibodies in diagnosing celiac disease: acomparison of four different commercial kits for anti‐tTG determination. J Clin Lab Anal 15:112–115. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3. Troncone R, Maurano F, Rossi M, et al. 1999. IgA antibodies to tissue transglutaminase: an effective diagnostic test for celiac disease. J Pediatr 134:166–171. [DOI] [PubMed] [Google Scholar]
  • 4. Dieterich W, Ehnis T, Bauer M, et al. 1997. Identification of tissue transglutaminase as the autoantigen of celiac disease. Nat Med 3:797–801. [DOI] [PubMed] [Google Scholar]
  • 5. Quarsten H, Molberg O, Fugger L, McAdam SN, Sollid LM. 1999. HLA binding and T cell recognition of a tissue transglutaminase‐modified gliadin epitope. Eur J Immunol 29:2506–2514. [DOI] [PubMed] [Google Scholar]
  • 6. van de Wal Y, Kooy Y, van Veelen P, et al. 1998. Cutting edge: selective deamidation by tissue transglutaminase strongly enhances gliadin‐specific T cell reactivity. J Immunol 161:1585–1588. [PubMed] [Google Scholar]
  • 7. Arentz‐Hansen H, Korner R, Molberg O, et al. 2000. The intestinal T cell response to alpha‐gliadin in adult celiac disease is focused on a single deamidated glutamine targeted by tissue transglutaminase. J Exp Med 191:603–612. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8. Corazza G, Valentini RA, Frisoni M, et al. 1992. Gliadin immune reactivity is associated with overt and latent enteropathy in relatives of celiac patients. Gastroenterology 103:1517–1522. [DOI] [PubMed] [Google Scholar]
  • 9. Sollid LM, Thorsby E. 1993. HLA susceptibility genes in celiac disease: genetic mapping and role in pathogenesis. Gastroenterology 105:910–922. [DOI] [PubMed] [Google Scholar]
  • 10. Spurkland A, Sollid LM, Ronningen KS, et al. 1990. Susceptibility to develop celiac disease is primarily associated with HLA‐DQ alleles. Hum Immunol 29:157–165. [DOI] [PubMed] [Google Scholar]
  • 11. Holmes GKT, Prior P, Lane MR, Pope D, Allan RN. 1989. Malignancy in coeliac disease‐effect of a gluten free diet. Gut 30:333–338. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12. 1990. Report of Working Group of European Society of Paediatric Gastroenterology and Nutrition. Revised criteria for diagnosis of coeliac disease. Arch Dis Child 65:909–911. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13. Sacchetti L, Ferrajolo A, Salerno G, et al. 1996. Diagnostic value of various serum antibodies detected by diverse methods in childhood celiac disease. Clin Chem 42:1838–1842. [PubMed] [Google Scholar]
  • 14. Scott H, Ek J, Havnen J, et al. 1990. Serum antibodies to dietary antigens: a prospective study of the diagnostic usefulness in celiac disease of children. J Pediatr Gastroenterol Nutr 11:215–220. [PubMed] [Google Scholar]
  • 15. Dieterich W, Laag E, Bruckner‐Tuderman L, et al. 1999. Antibodies to tissue transglutaminase as serologic markers in patients with dermatitis herpetiformis. J Invest Dermatol 113:133–136. [DOI] [PubMed] [Google Scholar]
  • 16. Grodzinsky E, Hed J, Skogh T. 1994. IgA antiendomysium antibodies have a high positive predictive value for celiac disease in asymptomatic patients. Allergy 49:593–597. [DOI] [PubMed] [Google Scholar]
  • 17. Sategna‐Guidetti C, Pulitano R, Grosso S, Ferfoglia G. 1993. Serum IgA antiendomysium antibody titers as a marker of intestinal involvement and diet compliance in adult celiac sprue. J Clin Gastroenterol 17:123–127. [DOI] [PubMed] [Google Scholar]
  • 18. Scott H, Ek J, Brandtzaeg P. 1985. Changes of serum antibody activities to various dietary antigens related to gluten withdrawal or challenge in children with coeliac disease. Int Arch Allergy Appl Immunol 76:138–144. [DOI] [PubMed] [Google Scholar]
  • 19. Troncone R, Mayer M, Spagnuolo F, et al. 1995. Endomysial antibodies as unreliable markers for slight dietary transgressions in adolescents with celiac disease. J Pediatr Gastroenterol Nutr 21:69–72. [DOI] [PubMed] [Google Scholar]
  • 20. Troncone R, Greco L, Mayer M, et al. 1996. Latent and potential coeliac disease. Acta Paediatr Suppl 412:10–14. [DOI] [PubMed] [Google Scholar]
  • 21. Hill I, Fasano A, Schwartz R, et al. 2000. The prevalence of celiac disease in at‐risk groups of children in the United States. J Pediatr 136:86–90. [DOI] [PubMed] [Google Scholar]
  • 22. Rostami K, Mulder CJ, Werre JM, et al. 1999. High prevalence of celiac disease in apparently healthy blood donors suggests a high prevalence of undiagnosed celiac disease in the Dutch population. Scand J Gastroenterol 34:276–279. [DOI] [PubMed] [Google Scholar]
  • 23. Not T, Horvath K, Hill ID, et al. 1998. Celiac disease risk in the USA: high prevalence of antiendomysium antibodies in healthy blood donors. Scand J Gastroenterol 33:494–498. [DOI] [PubMed] [Google Scholar]
  • 24. Lindh E, Ljunghall S, Larsson K, Lavö B. 1992. Screening for antibodies against gliadin in patients with osteoporosis. J Intern Med 231:403–406. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Laboratory Analysis are provided here courtesy of Wiley

RESOURCES